GSK Stockmann advised BioLabs Coworking Space GmbH on its expansion in Germany and on the conclusion of a lease agreement in the Heidelberg Innovation Park (HIP).
Based in Boston, USA, BioLabs is a global network for life science start-ups that supports young innovators in the start-up and growth phase by providing the critical infrastructure they need. BioLabs was founded in 2009 by Johannes Fruehauf and is the leading co-working company in the life science and biotechnology sector in the USA. In addition to its twelve locations in the United States, the company has also opened incubators for European biotech start-ups in both Germany and France. In opening the first European BioLabs location in Heidelberg, Johannes Fruehauf is bringing the concept back to the region where he himself grew up.
BioLabs has rented 2,400 sqm of space on the Heidelberg Innovation Park (HIP) campus, which is supported by the city of Heidelberg. BioLabs will use these premises to provide tech start-ups with licensed, fully equipped laboratories. BioLabs tenants also receive extensive support and mentoring from the company and its partners.
A GSK Stockmann team led by Heidelberg-based partner Martin Prothmann provided comprehensive legal advice to BioLabs on the negotiation and conclusion of the lease agreement as well as other related contracts and legal issues.
Advisers of BioLabs Coworking Space GmbH:
GSK Stockmann: Martin Prothmann (lead, Real Estate Transactions & Investments), Dirk Koch (Tax); Simon Rieger (Real Estate Transactions & Investments), Mona Glenc (Project Development)
